Skip to main content
TipRanks
Go Ultimate75% OFF

Fusion Antibodies Plc (FAB) Share Forecast & Price Target

10 Followers
See the Price Targets and Ratings of:

FAB Analyst Ratings

Currently, no data available

FAB Stock 12 Month Forecast

There Are No Analyst Ratings for FAB In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:FAB
Price TargetArticle
TipRanks - PerPlexity5 p→4 psell-5.88%DownsideReiterated11/11/26
TipRanks - Google5 p→4 psell-5.88%DownsideReiterated11/11/26
TipRanks - Anthropic5 p→4 psell-5.88%DownsideReiterated11/11/26
TipRanks - OpenAI5 p→4 phold-5.88%DownsideReiterated11/11/26
TipRanks - DeepSeek5 p→4 phold-5.88%DownsideReiterated11/11/26
TipRanks - xAI5 p→4 phold-5.88%DownsideReiterated11/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PVLAPalvella Therapeutics
IRLAIRulya Therapeutics
RZLTRezolute
PTGXProtagonist Therapeutics
CTMXCytomX Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fusion Antibodies Plc

3 Months
PerPlexity Health Care GB
PerPlexity Health Care GBTipRanks - PerPlexity
Success Rate1/3 ratings generated profit
33%
Average Return
-2.43%

Copying PerPlexity Health Care GB's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -2.43% per trade.

1 Year
PerPlexity Health Care GB
PerPlexity Health Care GBTipRanks - PerPlexity
Success Rate1/3 ratings generated profit
33%
Average Return
-2.43%

Copying PerPlexity Health Care GB's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.43% per trade.

2 Years
PerPlexity Health Care GB
PerPlexity Health Care GBTipRanks - PerPlexity
Success Rate1/3 ratings generated profit
33%
Average Return
-2.43%

Copying PerPlexity Health Care GB's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -2.43% per trade.

FAB Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for FAB
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, FAB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. FAB average Analyst price target in the past 3 months is ―.

FAB Financial Forecast

-2-1.5-1-0.50Q4 2025Q4 2026Q2 2027
Consensus-0.01

FAB Earnings Forecast

Next quarter’s earnings estimate for FAB is -GBX 0.01 with a range of ― to ―. The previous quarter’s EPS was -GBX 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

757,999886,499.51M1.1M1.3MQ4 2025Q4 2026Q2 2027
Consensus1.27M

FAB Sales Forecast

Next quarter’s sales forecast for FAB is GBX 1.27M with a range of ― to ―. The previous quarter’s sales results were GBX 1.27M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

FAB Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Fusion Antibodies Plc?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Fusion Antibodies Plc?
To buy shares of GB:FAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.